Raynaud Phenomenon Secondary to Systemic Sclerosis
2 clinical trials · Condition
◉ Watch Raynaud Phenomenon Secondary to Systemic Sclerosis
| Record | Firm | Date |
|---|---|---|
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) (NCT03867097) | Civi Biopharma, Inc. | 2019-03-07 |
| Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis (NCT03717961) | Assistance Publique - Hôpitaux de Paris | 2018-10-15 |
Track Raynaud Phenomenon Secondary to Systemic Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.